Endothelial dysfunction in the regulation of cirrhosis and portal hypertension

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Liver international (Print)

• Publication date

  2012-02-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/j.1478-3231.2011.02579.xPMID 21745318PMCID PMC3676636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Systemic and Splanchnic Circulations

  2011cited by this paper
• Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction

  2011cited by this paper
• Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?

  2010cited by this paper
• Endothelial cell toll‐like receptor 4 regulates fibrosis‐associated angiogenesis in the liver

  2010influential reference
• Gastrointestinal , Hepatobiliary and Pancreatic Pathology Endothelial to Mesenchymal Transition via Transforming Growth Factor-1 / Smad Activation Is Associated with Portal Venous Stenosis in Idiopathic Portal Hypertension

  2010cited by this paper
• In Hepatic Fibrosis, Liver Sinusoidal Endothelial Cells Acquire Enhanced Immunogenicity

  2010cited by this paper
• Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells.

  2010cited by this paper
• Extracellular matrix, inflammation, and the angiogenic response.

  2010cited by this paper
• Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration

  2010cited by this paper
• Endothelial progenitor cells--an evolving story.

  2010cited by this paper
• A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension

  2010influential reference
• Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific

  2010cited by this paper
• TARGETED MUTATION OF CAV-1 ALLEVIATES THE EFFECT OF ENDOTOXIN IN THE INHIBITION OF ET-1-MEDIATED ENOS ACTIVATION IN THE LIVER

  2010cited by this paper
• Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver

  2010cited by this paper
• NCX-1000, a Nitric Oxide–Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study

  2010cited by this paper
• Ethanol-Induced Expression of ET-1 and ET-BR in Liver Sinusoidal Endothelial Cells and Human Endothelial Cells Involves Hypoxia-Inducible Factor-1α and MicroRNA-1991

  2009cited by this paper
• Vascular hyporesponsiveness to angiotensin II in rats with CCl4‐induced liver cirrhosis

  2009cited by this paper
• Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.

  2009cited by this paper
• Liver Sinusoidal Endothelial Cell Lectin, LSECtin, Negatively Regulates Hepatic T-Cell Immune Response

  2009cited by this paper
• Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury.

  2009cited by this paper
• Therapy for portal hypertension: What is our pipeline?

  2009cited by this paper
• ROCK Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle Cells

  2009cited by this paper
• Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

  2009cited by this paper
• Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension.

  2009cited by this paper
• Caveolin-1 mediates endotoxin inhibition of endothelin-1-induced endothelial nitric oxide synthase activity in liver sinusoidal endothelial cells.

  2009cited by this paper
• Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.

  2009cited by this paper
• Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.

  2008cited by this paper
• Mechanisms of extrahepatic vasodilation in portal hypertension

  2008cited by this paper
• Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension

  2008cited by this paper
• Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats

  2008cited by this paper
• Circulating endothelial cells in oncology: pitfalls and promises

  2008cited by this paper
• Endotoxin-induced defenestration of the hepatic sinusoidal endothelium: a factor in the pathogenesis of cirrhosis?

  2008cited by this paper
• H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase

  2008cited by this paper
• Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.

  2008cited by this paper
• Faculty Opinions recommendation of H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase.

  2008cited by this paper
• The Molecules: Mechanisms of Arterial Vasodilatation Observed in the Splanchnic and Systemic Circulation in Portal Hypertension

  2007influential reference
• Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension

  2007cited by this paper
• Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA

  2007cited by this paper
• microRNAs in vertebrate physiology and human disease.

  2007cited by this paper
• Sinusoidal remodeling and angiogenesis: A new function for the liver‐specific pericyte?

  2007cited by this paper
• Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability

  2007influential reference
• Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.

  2007cited by this paper
• Hepatic microvasculature in liver injury.

  2007cited by this paper
• Sinusoidal endothelial cell repopulation following ischemia/reperfusion injury in rat liver transplantation

  2007cited by this paper
• Vascular endothelial dysfunction in cirrhosis.

  2007influential reference
• Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.

  2007cited by this paper
• Vascular deterioration in cirrhosis: the big picture.

  2007influential reference
• Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats

  2007cited by this paper
• High‐density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

  2007cited by this paper
• Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats

  2007cited by this paper
• Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2.

  2007cited by this paper
• Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.

  2007cited by this paper
• Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats.

  2007cited by this paper
• Differential Effects of Oxidative Stress on Hepatic Endothelial and Kupffer Cell Eicosanoid Release in Response to Endothelin‐1

  2006cited by this paper
• Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptors

  2006cited by this paper
• Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis.

  2006cited by this paper
• The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis

  2006cited by this paper
• Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

  2006cited by this paper
• Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.

  2006cited by this paper
• Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state.

  2006influential reference
• Circulating endothelial cells: a novel marker of endothelial damage.

  2006cited by this paper
• The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule

  2006influential reference
• Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation.

  2006cited by this paper
• Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells

  2005cited by this paper
• Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.

  2005cited by this paper
• Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.

  2005cited by this paper
• Oxidative stress disrupts nitric oxide synthase activation in liver endothelial cells.

  2005cited by this paper
• LIVER FAILURE AND LIVER DISEASE

  2005cited by this paper
• Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes.

  2005cited by this paper
• Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2.

  2005cited by this paper
• Neovascularization, Angiogenesis, and Vascular Remodeling in Portal Hypertension

  2005cited by this paper
• MicroRNAs Modulate Hematopoietic Lineage Differentiation

  2004cited by this paper
• Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats.

  2004cited by this paper
• CONCISE REVIEW IN MECHANISMS OF DISEASE Angiogenesis in Chronic Inflammatory Liver Disease

  2004cited by this paper
• eNOS at a glance

  2004cited by this paper
• Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

  2004cited by this paper
• Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

  2004cited by this paper
• A pancreatic islet-specific microRNA regulates insulin secretion

  2004cited by this paper
• Role of Endothelial Dysfunction in Atherosclerosis

  2004cited by this paper
• Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein betagamma subunit signaling to protein jinase B/Akt.

  2003cited by this paper
• Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats.

  2003cited by this paper
• Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis.

  2003cited by this paper
• MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.

  2003cited by this paper
• A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats.

  2003cited by this paper
• Bacterial translocation up‐regulates GTP‐cyclohydrolase I in mesenteric vasculature of cirrhotic rats

  2003cited by this paper
• NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver.

  2003cited by this paper
• Endothelin-1 Activates Endothelial Cell Nitric-oxide Synthase via Heterotrimeric G-protein βγ Subunit Signaling to Protein Kinase B/Akt*

  2003cited by this paper
• Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer.

  2003cited by this paper
• Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.

  2003cited by this paper
• Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.

  2002cited by this paper
• In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats

  2002cited by this paper
• H2S-induced vasorelaxation and underlying cellular and molecular mechanisms

  2002cited by this paper
• Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice.

  2002cited by this paper
• Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension.

  2002cited by this paper
• H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms.

  2002cited by this paper
• ERRATA

  2001cited by this paper
• Endotoxin-Induced Maturation of MyD88-Deficient Dendritic Cells1

  2001cited by this paper
• Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy.

  2001cited by this paper

• When Atrial Fibrillation Meets Alcoholic Liver Cirrhosis: Can Direct Oral Anticoagulants Bridge the Therapeutic Gap?

  2026cites this paper
• Impact of Early-Line Systemic Therapies on Liver Function in Hepatocellular Carcinoma: Longitudinal Change of ALBI Score and Ammonia Level With and Without Anti-VEGF Agents.

  2026cites this paper
• Endocan, a Potential Biomarker of Endothelial Dysfunction: A Brief Overview.

  2025cites this paper
• Advances in the Application of Computational Fluid Dynamics for Hemodynamic Assessment in the Portal Venous System

  2025cites this paper
• From cooperation to collapse: systemic failure in liver disease through a sociological lens

  2025cites this paper
• Development of a retinal vascular nomogram for predicting hepatitis B virus-related cirrhosis: insights into extrahepatic microcirculatory dysfunctions.

  2025cites this paper
• The effect of a plant- and dairy-based protein diet on serum levels of inflammatory and oxidative stress biomarkers in patients with liver cirrhosis: a randomized controlled trial

  2025cites this paper
• High Suitcordance for Panvascular Full-Watershed Organs: A New Interventional Perspective

  2025cites this paper
• Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic rats

  2025cites this paper
• The immunological profile of children with portal hypertension.

  2025cites this paper
• Portal vein hemodynamics measured by 4D flow MRI in predicting minimal hepatic encephalopathy in chronic hepatic schistosomiasis patients

  2025cites this paper
• New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis

  2025cites this paper
• The application of computational fluid dynamics in hepatic portal vein haemodynamics research: a narrative review

  2025cites this paper
• The Covert Side of Ascites in Cirrhosis: Cellular and Molecular Aspects

  2025cites this paper
• Endothelial dysfunction in single ventricle physiology and the Fontan circulation – What lies ahead

  2025cites this paper
• Study on Liver Sinusoidal Endothelial Cell Fenestrations Based on Cellular Omics-Structure Integration Technology and Its Application in Metabolic Diseases

  2025cites this paper
• Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management

  2025cites this paper
• Isolation and immortalization of human portal vein endothelial cells: A novel research tool for studying splanchnic vasculature

  2025cites this paper
• Chronic heart failure induces early defenestration of liver sinusoidal endothelial cells (LSECs) in mice

  2024cites this paper
• Single-cell analysis of the amphioxus hepatic caecum and vertebrate liver reveals genetic mechanisms of vertebrate liver evolution

  2024cites this paper
• NOSTRIN is an emerging negative regulator of decompensated cirrhotic patients with portal hypertension.

  2024cites this paper
• Die Leberzirrhose als Multisystemerkrankung

  2024cites this paper
• The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model

  2024cites this paper
• Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis

  2024cites this paper
• Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (Review)

  2024cites this paper
• Statins in Cirrhosis: Hope or Hype?

  2023cites this paper
• Preservation of vascular endothelial glycocalyx and barrier by activation of adenosine A2A receptor (A2AR) improved renal dysfunction in cirrhotic rats.

  2023cites this paper
• Single-cell transcriptomic dissection of the cellular and molecular events underlying the triclosan-induced liver fibrosis in mice

  2023cites this paper
• Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis

  2023cites this paper
• Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl4-induced liver fibrosis: Emphasis on gal-1/NRP-1/TGF-β and gal-1/NRP-1/VEGFR2 pathways.

  2023cites this paper
• Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab

  2023cites this paper
• The evolving role of liver sinusoidal endothelial cells in liver health and disease.

  2023cites this paper
• Oxidative Stress in Liver Pathophysiology and Disease

  2023cites this paper
• Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis

  2023cites this paper
• Bleeding and thrombosis in cirrhosis.

  2022cites this paper
• Synergistic antioxidant and anti-inflammatory action of N-acetylcysteine in portal hypertensive gastropathy in rats

  2022cites this paper
• Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications

  2022cites this paper
• Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats.

  2022cites this paper
• Low viscoelastic clot strength, platelet transfusions, and graft dysfunction are associated with persistent postoperative ascites following liver transplantation.

  2022cites this paper
• XSSJS inhibits hepatic fibrosis by promoting the miR-29b-3p/VEGFA axis in vitro and in vivo

  2022cites this paper
• Dissection of cellular and molecular mechanisms of aristolochic acid-induced hepatotoxicity via single-cell transcriptomics

  2022cites this paper
• SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency

  2022cites this paper
• Study on the Mechanism of Blood Circulation in Patients with Liver Fibrosis

  2022cites this paper
• Ascites After Liver Transplantation

  2021cites this paper
• Portal Vein Thrombosis in Patients with Cirrhosis

  2021cites this paper
• The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer

  2021cites this paper
• Portal Vein Thrombosis in Cirrhosis.

  2021cites this paper
• Use of the volume-averaged Murray's deviation method for the characterization of branching geometry in liver fibrosis: a preliminary study on vascular circulation.

  2021cites this paper
• Ablation probes

  2021cites this paper
• A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy.

  2021cites this paper
• Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma.

  2021cites this paper
• Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study

  2021cites this paper
• Maternal microvascular dysfunction during preeclamptic pregnancy.

  2021cites this paper
• GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension

  2021cites this paper
• Portal and Mesenteric Vein Thrombosis Associated with Hyperthyroidism

  2021cites this paper
• Management of portal hypertension based on portal hemodynamics

  2021cites this paper
• Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.

  2021cites this paper
• Variceal Bleeding in Liver Cirrhosis

  2021cites this paper
• Milzvolumen als diagnostischer Parameter bei Leberzirrhose und der Morbidität durch portale Hypertension

  2020cites this paper
• Cardiac baroreflex function and vascular reactivity recovery after aerobic exercise in patients with early cirrhosis

  2020cites this paper
• Percutaneous liver biopsy: another option of hepatic sample collection approach in single-cell sequencing studies?

  2020cites this paper
• Blunted blood pressure response to exercise and isolated muscle metaboreflex activation in patients with cirrhosis.

  2020cites this paper
• Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia

  2020cites this paper
• The vascular endothelial growth factor signaling pathway regulates liver sinusoidal endothelial cells during liver regeneration after partial hepatectomy

  2020cites this paper
• Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct–ligated rats

  2020cites this paper
• Ectopic Varices in Liver Cirrhosis

  2020cites this paper
• Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease

  2020cites this paper
• Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

  2020cites this paper
• Pathophysiology of Portal Hypertension

  2020cites this paper
• World Journal of Gastroenterology From to of via the gut-liver-brain axis in

  2020cites this paper
• Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine

  2020cites this paper
• Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study

  2020cites this paper
• Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis

  2020cites this paper
• Update on the management of gastrointestinal varices

  2019cites this paper
• The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver

  2019cites this paper
• The Wound-Healing Portal Hypertensive Response

  2019cites this paper
• The Role of the Renin-Angiotensin System and Vitamin D in Keloid Disorder—A Review

  2019cites this paper
• Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt

  2019cites this paper
• Evaluation with endothelial nitric oxide synthase (eNOS) immunoreactivity of the protective role of astaxanthin on hepatorenal injury of remote organs caused by ischaemia reperfusion of the lower extremities

  2019cites this paper
• Postoperative Portal Hypertension Enhances Alloimmune Responses after Living-Donor Liver Transplantation in Patients and in a Mouse Model

  2019cites this paper
• Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation

  2019cites this paper
• Vascular Targets for the Treatment of Portal Hypertension

  2019cites this paper
• J. ZUWALA-JAGIELLO1, M. PAZGAN-SIMON2, K. SIMON2, M. KUKLA3, E. MURAWSKA-CIALOWICZ4, E. GRZEBYK1 SERUM ENDOCAN LEVEL IN DIABETES MELLITUS OF PATIENTS WITH CIRRHOSIS AND RISK OF SUBSEQUENT DEVELOPMENT OF SPONTANEOUS BACTERIAL PERITONITIS

  2019cites this paper
• Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH

  2019cites this paper
• Bile acids elicited endothelium-dependent vasoconstrictor hypo-activity through TRPV4 channels in the thoracic aorta of bile duct ligation rats.

  2019cites this paper
• Вплив сірководню на кровообіг у печінці щурів при портальній гіпертензії

  2018cites this paper
• Angiotensin II receptor blockers for the treatment of portal hypertension in patients with liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials

  2018cites this paper
• Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy

  2018cites this paper
• The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis

  2018cites this paper
• The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease

  2018cites this paper
• Pathological findings that contribute to tissue stiffness in the spleen of liver cirrhosis patients

  2018cites this paper
• The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management

  2018cites this paper
• Ascites: A marker for increased surgical risk unaccounted for by the model for end‐stage liver disease (MELD) score for general surgical procedures

  2018cites this paper
• Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats

  2018cites this paper
• Surveillance for portal hypertension in the course of liver cirrhosis

  2018cites this paper
• No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial

  2018cites this paper
• Hepatic injury induced by thioacetamide causes aortic endothelial dysfunction by a cyclooxygenase‐dependent mechanism

  2018cites this paper
• Titanium Dioxide Nanoparticles Enhance Leakiness and Drug Permeability in Primary Human Hepatic Sinusoidal Endothelial Cells

  2018cites this paper
• Gastrointestinal and Hepatic Physiology in Liver Disease

  2018cites this paper
• Antibiotic prophylaxis versus placebo or no intervention for people with cirrhosis and variceal bleeding

  2018cites this paper